Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease by Mostafa, SA, Coleman, RL, Agbaje, OF, Gray, AM, Holman, RR, Bethel, MA

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT by Griffin, SJ, Bethel, MA, Holman, RR, Khunti, K, Wareham, N, Brierley, G, Davies, M, Dymond, A, Eichenberger, R, Evans, P, Gray, A, Greaves, C, Harrington, K, Hitman, G, Irving, G, Lessels, S, Millward, A, Petrie, JR, Rutter, M, Sampson, M, Sattar, N, Sharp, S